London has established itself as the largest tech hub in Europe by attracting investors and playing a role in launching several tech unicorn companies. The city has over three million people working in tech and has been popular among cloud developers and biotech researchers. Below, we picked some of the top startups in London to know.
Top London Startups to Know
- Cleo
- Globality
- Robin AI
- Packfleet
- Myricx Bio
Top London Startups to Know
Cleo is a financial assistant and banking platform that has raised over $140 million in funding. The London-founded fintech company provides budgeting tools, cash advances, savings accounts and a credit card that helps users build their credit scores. Cleo launched in 2016 and integrated ChatGPT into its platform to provide users with personal insights and spending challenges.
Globality is an AI company with offices in Silicon Valley and London. Its AI platform is geared toward enterprises as it helps businesses improve their financial outcomes. Globality’s AI, called GLO, provides analyses, cost comparisons and e-negotiations that can help with spending and vendor management.
Robin AI works with Anthropic’s platform to provide legal assistance, including generating and reviewing contracts. The company also leverages AI to cull through contact data and find specific clauses, terms and obligations in seconds. Robin AI launched in 2019 but has had a stellar year, having secured $26 million from investors.
Packfleet is a logistics and e-commerce startup founded by alumni of the popular fintech app Monzo. The company operates an all-electric vehicle fleet that helps companies ship parcels throughout the United Kingdom while adhering to carbon-neutrality initiatives. As part of its platform, Packfleet has also developed a robust logistics platform that handles parcel pickup, delivery management and returns.
Myricx Bio is a biotech company that has raised serious cash from investors in recent years. The London-based company develops payloads for antibody treatments to treat some forms of cancer. According to the company, its developments are creating new targeted biotherapeutic methods.
